You say it is BS, but don't dispute any of the info presented. Bought a position yesterday prior to the SA article. Not in love with it, but they have a great pipeline for the size, a number of ongoing trials, and a catalyst in the offing. Pretty good financial position, low float and analysts' recommendations of buy. At close to a 2 year low. What is not to like at this time?
News 
Market Data 
Discover 
AI
